Back to Search Start Over

Lentinan progress in inflammatory diseases and tumor diseases.

Authors :
Zhou, Guangda
Liu, Haiyan
Yuan, Ying
Wang, Qian
Wang, Lanping
Wu, Jianghua
Source :
European Journal of Medical Research; 1/3/2024, Vol. 29 Issue 1, p1-12, 12p
Publication Year :
2024

Abstract

Shiitake mushrooms are a fungal food that has been recorded in Chinese medicine to nourish the blood and qi. Lentinan (lLNT) is an active substance extracted from shiitake mushrooms with powerful antioxidant, anti-inflammatory, anti-tumor functions. Inflammatory diseases and cancers are the leading causes of death worldwide, posing a serious threat to human life and health and posing enormous challenges to global health systems. There is still a lack of effective treatments for inflammatory diseases and cancer. LNT has been approved as an adjunct to chemotherapy in China and Japan. Studies have shown that LNT plays an important role in the treatment of inflammatory diseases as well as oncological diseases. Moreover, clinical experiments have confirmed that LNT combined with chemotherapy drugs has a significant effect in improving the prognosis of patients, enhancing their immune function and reducing the side effects of chemotherapy in lung cancer, colorectal cancer and gastric cancer. However, the relevant mechanism of action of the LNT signaling pathway in inflammatory diseases and cancer. Therefore, this article reviews the mechanism and clinical research of LNT in inflammatory diseases and tumor diseases in recent years. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09492321
Volume :
29
Issue :
1
Database :
Complementary Index
Journal :
European Journal of Medical Research
Publication Type :
Academic Journal
Accession number :
174580142
Full Text :
https://doi.org/10.1186/s40001-023-01585-7